U.S. markets closed

Movers roundup: Dendreon, Smart Balance

The Associated Press

Among the stock activity stories for Monday, June 4, from AP Business News:

— Shares of drug developer Dendreon Corp. slumped after Johnson & Johnson reported positive clinical data for a prostate cancer drug that competes with Dendreon's therapy Provenge.

— Smart Balance Inc.'s stock climbed as an analyst upgraded the food maker's rating and price target, saying its buyout of gluten free foods maker Udi's Healthy Foods LLC will help with its growth.